TrialHuman vaccines & immunotherapeutics2017

Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly.

Peter Vink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.